Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians Sithara RamdasMaryam OskouiLaurent Servais Current Opinion 15 June 2024
Therapeutic Potential of Lipoprotein(a) Inhibitors Stephen J. Nicholls Leading Article Open access 08 June 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan Carlo LombardiPasquale ComberiatiAlvise Berti Review Article Open access 08 June 2024
Correction: Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain Hannah A. Blair Correction 30 May 2024
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions Cindy-Lee DennisDaisy R. SinglaSimone N. Vigod Review Article 30 May 2024
Correction: Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo Connie Kang Correction Open access 29 May 2024
Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Ibrahim AkinNazha HamdaniIbrahim El-Battrawy Commentary 29 May 2024
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis Thomas A. AgbaedengJean Jacques NoubiapAzmeraw T. Amare Systematic Review 29 May 2024
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned Sarah A. JonesEric F. Morand Leading Article Open access 28 May 2024
Drugs in Development to Treat IgA Nephropathy Lucia Del VecchioMarco AllinoviFrancesco Locatelli Leading Article 23 May 2024
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments Javier Torres-JiménezJavier Baena EspinarLuis Paz-Ares Correction 13 May 2024
Correction: Vonoprazan: A Review in Helicobacter pylori Infection Matt Shirley Correction Open access 13 May 2024
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines Congrui ZhuShengmei PangQiangde Duan Review Article 23 April 2024 Pages: 403 - 423
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease David Valdés-AriasElyana V. T. LocatelliAnat Galor Review Article Open access 23 April 2024
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Sarah E. ThomasLiana BarenbrugJuul M. P. A. van den Reek Systematic Review Open access 17 April 2024
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders Vito D’AgnanoDomenica Francesca MarinielloFabio Perrotta Leading Article Open access 17 April 2024
Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo Connie Kang Adis Drug Evaluation Open access 16 April 2024
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments Javier Torres-JiménezJavier Baena EspinarLuis Paz-Ares Review Article 16 April 2024
Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain Hannah A. Blair Adis Drug Evaluation Open access 09 April 2024 Pages: 449 - 457
The Pharmacological Landscape for Fatty Change of the Pancreas Maxim S. Petrov Leading Article Open access 04 April 2024 Pages: 375 - 384
Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease Amy Zhuang-YanYahiya Y. Syed Adis Drug Evaluation 30 March 2024 Pages: 441 - 448
Correction: Eplontersen: First Approval Tina Nie Correction Open access 28 March 2024 Pages: 489 - 489
Correction: Zilucoplan: First Approval Matt Shirley Correction Open access 19 March 2024 Pages: 373 - 373
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1 Connie Kang Correction Open access 15 March 2024 Pages: 371 - 371
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability Alise K. CarlsonMoein AminJeffrey A. Cohen Review Article Open access 14 March 2024 Pages: 285 - 304
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects? Sanne M. BuijsStijn L. W. KoolenAgnes Jager Review Article Open access 14 March 2024 Pages: 385 - 401
Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials Yifan WangHe YiLing Li Systematic Review 13 March 2024 Pages: 425 - 439
Fidanacogene Elaparvovec: First Approval Sohita Dhillon AdisInsight Report 12 March 2024 Pages: 479 - 486
Opioids for Acute Musculoskeletal Pain: A Systematic Review with Meta-Analysis Caitlin M. P. JonesAili LangfordChung-Wei Christine Lin Systematic Review Open access 07 March 2024 Pages: 305 - 317
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection Hannah A. Blair Adis Drug Evaluation 05 March 2024 Pages: 329 - 336
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options Sara BindoliChiara BaggioPaolo Sfriso Review Article Open access 05 March 2024 Pages: 257 - 274
Microencapsulated Benzoyl Peroxide for Rosacea in Context: A Review of the Current Treatment Landscape Seemal R. DesaiHilary BaldwinLinda Stein Gold Review Article Open access 29 February 2024 Pages: 275 - 284
Eplontersen: First Approval Tina Nie AdisInsight Report Open access 28 February 2024 Pages: 473 - 478
A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder Michael A. NorredZachary D. ZuschlagMark B. Hamner Review Article 28 February 2024 Pages: 149 - 164
Berdazimer Topical Gel, 10.3%: First Approval Susan J. Keam AdisInsight Report 27 February 2024 Pages: 363 - 368